Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Lin

Showing results (81-90 of 287) with videos related to

Pageof 29
Sort By:
European Urology|January 13, 2018
Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic CancersGladell P Paner, Walter M Stadler, Donna E Hansel, et al.
Clinical Genitourinary Cancer|November 19, 2018
Pathologic Nodal Involvement in Patients With Penile Cancer With Cavernosal Versus Spongiosal InvolvementJames T Kearns, Brian D Winters, Sarah K Holt, et al.
Journal of the National Cancer Institute|March 2, 2011
Influence of publication of US and European prostate cancer screening trials on PSA testing practicesSteven B Zeliadt, Richard M Hoffman, Ruth Etzioni, et al.
Expert Review of Anticancer Therapy|November 15, 2013
Sequencing therapy in advanced prostate cancer: focus on sipuleucel-TDavid I Quinn, Ulka Vaishampayan, Celestia S Higano, et al.
Cancer|May 22, 2018
PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screeningJames T Kearns, Sarah K Holt, Jonathan L Wright, et al.
The Journal of Urology|October 20, 2009
Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohortJonathan L Wright, Claudia A Salinas, Daniel W Lin, et al.
The Journal of Urology|November 15, 2021
Active Surveillance: Very Much "Preferred" for Low-Risk Prostate CancerMatthew R Cooperberg, Daniel W Lin, Todd M Morgan, et al.
Clinical Genitourinary Cancer|October 2, 2024
Impact of Baseline Renal Insufficiency on Piflufolastat F-18 Performance and Investigation of Changes in Renal Function Following Piflufolastat F-18 Administration: Results From the OSPREY TrialMeera R Chappidi, Amir Iravani, Nancy Stambler, et al.
The Journal of Urology|July 12, 2005
Prostate cancer in men using testosterone supplementationFranklin D Gaylis, Daniel W Lin, Jeffrey M Ignatoff, et al.
Urologic Oncology|August 31, 2015
Cystic renal cell carcinoma carries an excellent prognosis regardless of tumor sizeBrian R Winters, John L Gore, Sarah K Holt, et al.
Pageof 29

Showing results (81-90 of 287) with videos related to

Sort By:
Pageof 29
European Urology|January 13, 2018
Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic CancersGladell P Paner, Walter M Stadler, Donna E Hansel, et al.
Clinical Genitourinary Cancer|November 19, 2018
Pathologic Nodal Involvement in Patients With Penile Cancer With Cavernosal Versus Spongiosal InvolvementJames T Kearns, Brian D Winters, Sarah K Holt, et al.
Journal of the National Cancer Institute|March 2, 2011
Influence of publication of US and European prostate cancer screening trials on PSA testing practicesSteven B Zeliadt, Richard M Hoffman, Ruth Etzioni, et al.
Expert Review of Anticancer Therapy|November 15, 2013
Sequencing therapy in advanced prostate cancer: focus on sipuleucel-TDavid I Quinn, Ulka Vaishampayan, Celestia S Higano, et al.
Cancer|May 22, 2018
PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screeningJames T Kearns, Sarah K Holt, Jonathan L Wright, et al.
The Journal of Urology|October 20, 2009
Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohortJonathan L Wright, Claudia A Salinas, Daniel W Lin, et al.
The Journal of Urology|November 15, 2021
Active Surveillance: Very Much "Preferred" for Low-Risk Prostate CancerMatthew R Cooperberg, Daniel W Lin, Todd M Morgan, et al.
Clinical Genitourinary Cancer|October 2, 2024
Impact of Baseline Renal Insufficiency on Piflufolastat F-18 Performance and Investigation of Changes in Renal Function Following Piflufolastat F-18 Administration: Results From the OSPREY TrialMeera R Chappidi, Amir Iravani, Nancy Stambler, et al.
The Journal of Urology|July 12, 2005
Prostate cancer in men using testosterone supplementationFranklin D Gaylis, Daniel W Lin, Jeffrey M Ignatoff, et al.
Urologic Oncology|August 31, 2015
Cystic renal cell carcinoma carries an excellent prognosis regardless of tumor sizeBrian R Winters, John L Gore, Sarah K Holt, et al.
Pageof 29